Archives of Endocrinology and Metabolism (Nov 2021)

Pregnancy has no significant impact on the prognosis of differentiated thyroid cancer

  • Gabriela Maia Nobre,
  • Mariana Yoshii Tramontin,
  • Natalia Treistman,
  • Paulo Alonso Alves Junior,
  • Fernanda Accioly Andrade,
  • Daniel Alves Bulzico,
  • Rossana Corbo,
  • Fernanda Vaisman

DOI
https://doi.org/10.20945/2359-3997000000413
Journal volume & issue
Vol. 65, no. 6
pp. 768 – 777

Abstract

Read online

ABSTRACT Objective: To evaluate the impact of pregnancy on differentiated thyroid carcinomas (DTC) behavior Subjects and methods: Retrospective study of patients diagnosed with DTC before or during pregnancy and treated with standard therapy. In women diagnosed with DTC before pregnancy, we evaluated the occurrence of progression according to categories of response to therapy based on imaging and non-stimulated thyroglobulin (TG) levels. Results: Of 96 analyzed patients, 76 became pregnant after DTC treatment and 20 were diagnosed with DTC during pregnancy. Among women who became pregnant after a DTC diagnosis, no difference was observed regarding response to therapy before and after pregnancy. Disease progression after pregnancy was documented in six of these patients, while seven of them presented progression before pregnancy but were only treated after delivery. Patients with DTC diagnosed during pregnancy had a higher rate of distant metastases at diagnosis (30%) compared with the patients who became pregnant after DTC diagnosis (9.2%, p = 0.01). Conclusion: Pregnancy had no impact on the natural course of DTC. Disease progression after pregnancy was limited and probably related to more aggressive disease and higher risk stratification at diagnosis. Still, mild disease progression may have occurred asymptomatically in some patients.

Keywords